Open AccessRipasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Author(s) -
Mayuresh Naik,
Monika Kapur,
VishnuSwarup Gupta,
Harinder Singh Sethi,
Kartikeya Srivastava
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s318897
Subject(s) - medicine , ophthalmology , intraocular pressure , glaucoma , visual acuity
To elucidate the use of Ripasudil in patients of advanced glaucoma on maximally tolerated medical therapy who could not be offered the option of surgery due to the global pandemic lockdown.